Aeglea BioTherapeutics
Now Spyre (SYRE)

Spyre Therapeutics is a clinical-stage company creating next-generation inflammatory bowel disease (IBD) and other immune-mediated disease products.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2016
Stage of Initial Investment
Series B
Initial Investment Year
2015